Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Cash (2016 - 2025)

Historic Change in Cash for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.3 million.

  • Jaguar Health's Change in Cash rose 14748.2% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.8 million, marking a year-over-year decrease of 15656.56%. This contributed to the annual value of $1.5 million for FY2024, which is 5330.0% up from last year.
  • Per Jaguar Health's latest filing, its Change in Cash stood at $1.3 million for Q3 2025, which was up 14748.2% from -$3.5 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Change in Cash registered a high of $24.2 million during Q1 2021, and its lowest value of -$19.5 million during Q3 2021.
  • Its 5-year average for Change in Cash is -$240157.9, with a median of -$338000.0 in 2021.
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 239763.31% in 2022, then soared by 209703.7% in 2023.
  • Over the past 5 years, Jaguar Health's Change in Cash (Quarter) stood at $4.7 million in 2021, then plummeted by 208.9% to -$5.1 million in 2022, then surged by 163.69% to $3.2 million in 2023, then tumbled by 262.41% to -$5.3 million in 2024, then surged by 125.06% to $1.3 million in 2025.
  • Its Change in Cash stands at $1.3 million for Q3 2025, versus -$3.5 million for Q2 2025 and -$2.3 million for Q1 2025.